Miluše Hradilová

Unravelling heterogeneous effects of cancer-associated fibroblasts on poor prognosis markers in breast cancer EM-G3 cell line: In vitro-targeted treatment (anti-IL-6, anti-VEGF-A, anti-MFGE8) based on transcriptomic profiling

2024 | First Faculty of Medicine, Third Faculty of Medicine

Publication